Clinical Trials Logo

Clinical Trial Summary

The purpose of this open-label, single-dose, randomized, three-treatment, three-period, four-sequence, crossover study is to evaluate the relative bioavailability of a test formulation of lofexidine granules for reconstitution (oral) and LUCEMYRA tablets under fasted conditions and to evaluate the effect of food on the relative bioavailability of lofexidine granules for reconstitution (oral) when administered under fed compared to fasted conditions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04188730
Study type Interventional
Source USWM, LLC (dba US WorldMeds)
Contact
Status Completed
Phase Phase 1
Start date February 16, 2021
Completion date March 26, 2021

See also
  Status Clinical Trial Phase
Completed NCT05019950 - Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers Phase 1
Completed NCT01366339 - Tolerance and Pharmacokinetics Study of MNTX Tablets Phase 1
Completed NCT01862835 - Impact of Estradiol Addback Phase 1
Completed NCT01629446 - Lofexidine Mass Balance in Volunteers Phase 1
Completed NCT02026973 - Impact of Endogenous E2 on SSI and GH Rebound Phase 1
Completed NCT03860571 - Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers Phase 1
Recruiting NCT03234504 - Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display
Completed NCT02271282 - Estradiol-Receptor Blockade in Older Men and Women Phase 1
Withdrawn NCT03291158 - Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV Phase 1
Completed NCT02802631 - Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults Phase 1